Xanthones as antimalarial agents; studies of a possible mode of action

We recently demonstrated that 2,3,4,5,6‐pentahydroxyxanthone (X5) inhibits the in vitro growth of both chloroquine‐sensitive and multidrug‐resistant strains of P. falciparum. To study the molecular basis of its antimalarial action, we tested X5 and selected hydroxyxanthone analogs as inhibitors of in vitro heme polymerization in a low ionic strength phosphate solution at mildly acidic pH. We found that addition of 1 Eq. of X5 resulted in complete inhibition of polymerization in this system whereas addition of up to 40 Eqs. of standard antimalarial compounds (chloroquine, primaquine, quinacrine, artemisinin and methylene blue) had no such effect although these compounds did co‐precipitate with heme. The antimalarial potency of the hydroxyxanthones correlated well with their ability to inhibit in vitro heme polymerization in our assay, suggesting that these compounds exert their antimalarial action by preventing hemozoin formation. Based on the observed structure–activity relationships, we propose a model displaying possible interactions between hydroxyxanthones and heme.

[1]  M. Ignatushchenko,et al.  Potentiation of an antimalarial oxidant drug , 1997, Antimicrobial agents and chemotherapy.

[2]  D. Sullivan,et al.  On the molecular mechanism of chloroquine's antimalarial action. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A. Cerami,et al.  Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites , 1992, Nature.

[4]  S. Meshnick.  Is haemozoin a target for antimalarial drugs? , 1996, Annals of tropical medicine and parasitology.

[5]  D. Goldberg,et al.  An iron-carboxylate bond links the heme units of malaria pigment. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Ignatushchenko,et al.  Potentiation of the antimalarial agent rufigallol , 1996, Antimicrobial agents and chemotherapy.

[7]  W. Trager,et al.  Human malaria parasites in continuous culture. , 1976, Science.

[8]  B. Tekwani,et al.  Formation of haemozoin/β‐haematin under physiological conditions is not spontaneous , 1996, FEBS letters.

[9]  D. Goldberg,et al.  The plasmodium digestive vacuole: metabolic headquarters and choice drug target. , 1995, Parasitology today.

[10]  S. Meshnick,et al.  Effects of antimalarials and protease inhibitors on plasmodial hemozoin production. , 1994, Molecular and biochemical parasitology.

[11]  R. Dinnebier,et al.  Characterization of the Products of the Heme Detoxification Pathway in Malarial Late Trophozoites by X-ray Diffraction* , 1997, The Journal of Biological Chemistry.

[12]  N. Weatherly,et al.  Plasmodium falciparum: cloning by single-erythrocyte micromanipulation and heterogeneity in vitro. , 1988, Experimental parasitology.

[13]  H. Vial,et al.  Use of radioactive ethanolamine incorporation into phospholipids to assess in vitro antimalarial activity by the semiautomated microdilution technique , 1992, Antimicrobial Agents and Chemotherapy.

[14]  C. D. Fitch,et al.  The state of ferriprotoporphyrin IX in malaria pigment. , 1987, The Journal of biological chemistry.

[15]  H. Ginsburg,et al.  Mode of antimalarial effect of methylene blue and some of its analogues on Plasmodium falciparum in culture and their inhibition of P. vinckei petteri and P. yoelii nigeriensis in vivo. , 1996, Biochemical pharmacology.

[16]  H. Matile,et al.  Malarial haemozoin/β-haematin supports haem polymerization in the absence of protein , 1995, Nature.

[17]  M. Foley,et al.  Novel bisquinoline antimalarials. Synthesis, antimalarial activity, and inhibition of haem polymerisation. , 1996, Biochemical pharmacology.

[18]  T. Egan,et al.  Quinoline anti‐malarial drugs inhibit spontaneous formation of β‐haematin (malaria pigment) , 1994 .